ENDECE, LLC
Mequon, USA
|
ENDECE is focused on developing proprietary novel drugs that impact lung inflammation, neuroinflammation and neurodegeneration in chronic, debilitating, and life threatening diseases for which treatment options are limited or non-existent. The company's library of proprietary compounds is designed to activate multiple genes within specific biological pathways to stop progression, repair damage, and restore function for people with diseases such as Multiple Sclerosis (MS), Acute Respiratory Distress...